Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Watson

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Sports Medicine Reports|December 9, 2021
Mindfulness in AthletesScott A Anderson, Kristin Haraldsdottir, Drew Watson
BMC Cancer|December 24, 2010
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer AssayKim M Clark-Langone, Chithra Sangli, Jayadevi Krishnakumar, et al.
Journal of Circulating Biomarkers|January 11, 2020
Analytical validation of the CellMax platform for early detection of cancer by enumeration of rare circulating tumor cellsPratyush Gupta, Zulfiqar Gulzar, Ben Hsieh, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Analytical Validation of Relative Average Telomere Length Measurement in a Clinical Laboratory EnvironmentMarsha N Blauwkamp, Clare L Fasching, Jue Lin, et al.
Clinical Chemistry|April 28, 2007
Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancerMaureen Cronin, Chithra Sangli, Mei-Lan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20Eleftherios P Mamounas, Gong Tang, Bernard Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapyFrancisco J Esteva, Aysegul A Sahin, Massimo Cristofanilli, et al.
Breast Cancer Research and Treatment|October 14, 2006
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissueLida Mina, Sharon E Soule, Sunil Badve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorinMichael J O'Connell, Ian Lavery, Greg Yothers, et al.
BMC Genomics|October 10, 2013
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsiesDejan Knezevic, Audrey D Goddard, Nisha Natraj, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Sports Medicine Reports|December 9, 2021
Mindfulness in AthletesScott A Anderson, Kristin Haraldsdottir, Drew Watson
BMC Cancer|December 24, 2010
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer AssayKim M Clark-Langone, Chithra Sangli, Jayadevi Krishnakumar, et al.
Journal of Circulating Biomarkers|January 11, 2020
Analytical validation of the CellMax platform for early detection of cancer by enumeration of rare circulating tumor cellsPratyush Gupta, Zulfiqar Gulzar, Ben Hsieh, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Analytical Validation of Relative Average Telomere Length Measurement in a Clinical Laboratory EnvironmentMarsha N Blauwkamp, Clare L Fasching, Jue Lin, et al.
Clinical Chemistry|April 28, 2007
Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancerMaureen Cronin, Chithra Sangli, Mei-Lan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20Eleftherios P Mamounas, Gong Tang, Bernard Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapyFrancisco J Esteva, Aysegul A Sahin, Massimo Cristofanilli, et al.
Breast Cancer Research and Treatment|October 14, 2006
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissueLida Mina, Sharon E Soule, Sunil Badve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorinMichael J O'Connell, Ian Lavery, Greg Yothers, et al.
BMC Genomics|October 10, 2013
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsiesDejan Knezevic, Audrey D Goddard, Nisha Natraj, et al.
Pageof 3